As an Innovation Challenge finalist, ZyDoc is pleased to collaborate with Redesigning Data and Health Datapalooza IV on focused efforts to improve health care for diabetics.
Islandia, NY (PRWEB) April 25, 2013
ZyDoc a New York-based medical informatics company, is pleased to announce that its MediSapien™ Clinical Data Repository application has been selected as one of five finalists in the Sanofi 2013 Data Design Diabetes Innovation Challenge – Prove It! (http://www.redesigningdata.com). MediSapien, an enterprise-class web-based platform that accepts isolated silos of unstructured data, empowers healthcare analytics and is highly customizable for diabetes management. Following a three-day Innovators’ Bootcamp, the ZyDoc technical team will work with Data Design Diabetes mentors to prepare the MediSapien CDR for a live demonstration at Health Datapalooza IV, June 3, 2013 in Washington, D.C.
ZyDoc’s selection for the 2013 Data Design Diabetes Innovation Challenge – Prove It! comes on the heels of another significant achievement for the company, an NIH SBIR grant for a research study, “Applying NLP to Free Text as an EHR Data Capture Method to Improve EHR Usability,” with participation by Columbia University.
According to ZyDoc Chairman James Maisel, MD, “ZyDoc is proving the efficiency and usability of dictation for structured data extraction and EHR insertion with our research grant. We are demonstrating the power of the MediSapien platform in real-world clinical settings. The combined ZyDoc and MediSapien platforms are currently being installed to fulfill a competitive RFP for a state psychiatric institute and are being integrated with several leading EHRs. As an Innovation Challenge finalist, we are pleased to collaborate with Redesigning Data and Health Datapalooza IV on focused efforts to improve health care for diabetics.”
Dr. Maisel, who is also founder and CEO of the Retina Group of New York, has cared for thousands of diabetic patients. “As a retinal specialist,” explains Maisel, “I have an extensive insight into the needs of the health care system for diabetes prevention, education, disease management, and coordination of care. Diabetes is a chronic disease that severely impacts millions of Americans and is becoming much more prevalent. We must improve outcomes, quality of care and control costs.
“The utility, power and flexibility of the MediSapien platform make it highly customizable for focus on diabetic health care,” continues Maisel. “We hope to fulfill the potential of the ZyDoc documentation and MediSapien knowledge management platforms by working with channel partners from the transcription, EHR, revenue cycle management and analytic arenas to enhance their functionality with rich text and highly structured granular data with standardized messages and seamless interoperability. We anticipate integrating many workflow-specific diabetic applications that will be able to extract relevant data elements from MediSapien and also use the platform to incorporate newly acquired patient-specific input into structured patient records.”
About ZyDoc and MediSapien
ZyDoc, based in Islandia, NY, was founded in 1993 to develop medical informatics technologies. Led by James Maisel, MD, Chairman, ZyDoc has developed award-winning e-transcription infrastructure and speech recognition solutions. Augmenting these solutions, ZyDoc launched MediSapien, an NLP-powered web-based platform that converts unstructured text to fully coded structured data for EHRs, analytics, and reporting. The MediSapien Knowledge Management Platform is powered by disruptive patent-pending proprietary technologies, and NLP technology from Health Fidelity. ZyDoc MediSapien solutions, including underlying key modular functions, are primarily marketed through a channel partner network, which includes EHRs, billing and RCM providers, analytics companies, and MTSOs. For clinician end-users, MediSapien can be utilized in conjunction with existing or planned EHR installations, and can facilitate compliance with Meaningful Use mandates. ZyDoc is a Philips Speech Processing Solutions USA Integrator Partner, and a Health Fidelity Solution Partner.
The ZyDoc Technical Development Team
Team leader James M. Maisel, MD has unique diabetes and medical informatics experience as CEO of ZyDoc and Retina Group of NY. Since training as the Dyson Foundation vitreoretinal fellow at NY Presbyterian Cornell, he has a strong record as a diabetes educator helping to train other diabetes educators and professionals, as well as the diabetes patient community, and has also served as a pharmaceutical medical advisor. Formerly CEO of HOST, he led ZyDoc in developing informatics technologies including a prototype EMR purchased by the DOD, speech recognition, e-transcription, and NLP. The team includes CTO Albert Llanes, Senior Project Manager Matt Bouchard, and Board Member Stan Esikoff.
About the 2013 Data Design Diabetes Innovation Challenge – Prove It!
Now in its third installment, the Data Design Diabetes Innovation Challenge invites all innovators, entrepreneurs, data scientists, and designers to create the evidence needed to make better decisions across the entire spectrum of diabetes. As part of the government-sponsored Redesigning Data Challenge Series, Data Design Diabetes calls on the innovation community to creatively apply or generate data that can fuel the tools to help make the right decisions with the right information at the right time to improve diabetes in the US. Previous Data Design Diabetes winners include Ginger.io, an app that alerts caregivers to concerning behavioral changes, and n4a Diabetes Care Center, a team that uses predictive analysis to isolate and target patients and provide them with support based on cost patterns and risk profiles.
Research reported in this publication was supported by the National Library of Medicine of the National Institutes of Health under Award Number R43LM011165. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.